Literature DB >> 9438391

mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.

Y C Chang1, Y S Lee, T Tejima, K Tanaka, S Omura, N H Heintz, Y Mitsui, J Magae.   

Abstract

Upon activation in response to cellular stress or DNA damage, the p53 tumor suppressor induces the expression of gene products involved in cell cycle arrest and apoptosis. Using the proteasome-specific inhibitors, MG132 (N-acetyl-L-leucinyl-L-leucinal-L-leucinal) and lactacystin, here we show that the p53-response proteins, bax and mdm2 as well as p21, are degraded by the ubiquitin-proteasome pathway in HeLa cells. MG132 also increased expression of the three proteins in cells that lack p53, showing that stabilization of the p53 response proteins is not due to increased levels of p53 itself. Increases in mdm2 protein levels by MG132 was accompanied by increases in polyubiquitinated forms of the proteins. Our results indicate that ubiquitin-dependent protein degradation influences the turnover of downstream targets of p53, therefore suggesting that the proteasome plays a role in regulating apoptosis and cell cycle arrest in response to p53.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9438391

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  28 in total

1.  Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

Authors:  A Seluanov; V Gorbunova; A Falcovitz; A Sigal; M Milyavsky; I Zurer; G Shohat; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

3.  Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.

Authors:  X M Zhang; H Lin; C Chen; B D Chen
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

4.  Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.

Authors:  Jing Nie; Ping Xie; Lin Liu; Guichun Xing; Zhijie Chang; Yuxin Yin; Chunyan Tian; Fuchu He; Lingqiang Zhang
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

5.  Condensation by DNA looping facilitates transfer of large DNA molecules into mammalian cells.

Authors:  W J Montigny; C R Houchens; S Illenye; J Gilbert; E Coonrod; Y C Chang; N H Heintz
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

6.  Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Authors:  J S Foster; D C Henley; A Bukovsky; P Seth; J Wimalasena
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors.

Authors:  Zhihong Lai; Tao Yang; Young B Kim; Thais M Sielecki; Melody A Diamond; Peter Strack; Mark Rolfe; Maureen Caligiuri; Pamela A Benfield; Kurt R Auger; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

8.  Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity.

Authors:  Dingding Shi; Wei Gu
Journal:  Genes Cancer       Date:  2012-03

9.  Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.

Authors:  Xian Li; Da Xing; Ju Wang; De-Bin Zhu; Lan Zhang; Xiao-Jia Chen; Fen-Yong Sun; An Hong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 10.  Bortezomib: a review of its use in patients with multiple myeloma.

Authors:  Monique P Curran; Kate McKeage
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.